Evidence map›Paper›PMID 40411599›Full record

ArticleAnnals of hematology2025

Epidemiology and survival of patients with primary lymphoma of bone: a large retrospective cohort study.

Xiaojie Liang, Weixiang Lu, Tong Li, Baiwei Luo, Yuzhe Wu, Chaoran Lin, Yang Liu, Liang Wang

Abstract read
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaojie Liang *Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Weixiang Lu *Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Tong Li *Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, 510515, China.
Baiwei LuoDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Yuzhe WuStomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, 510515, China.
Chaoran LinThe First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, 524000, China.
Yang LiuStomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, 510515, China.
Liang WangDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. wangliangtrhos@126.com.

Funding

National Key Research and Development Program of China 2022YFF1502000National Natural Science Foundation of China 82170181
6 · The paper itself

Abstract

Primary lymphoma of bone (PLB) is a rare extranodal lymphoma, and its epidemiology and prognosis remain controversial. We conducted a retrospective analysis of 1,222 patients with PLB in the Surveillance, Epidemiology, and End Results (SEER) database to investigate its epidemiology and prognostic factors. The incidence of PLB peaked in 1992 with an average annual percent change of 1.72 after a significant rise from 1975 to 1992, followed by a general decline. The risk of death from PLB involves both patient and treatment factors. Survival analysis revealed that age, stage, laterality, chemotherapy, and primary site significantly influence both overall survival and disease-specific survival. We integrated and compared 99 machine learning algorithms, and identified the Random Survival Forest (RSF) model as the most effective for predicting PLB outcomes. Patients were stratified into low- and high-risk groups according to the RSF model score. The incidence of PLB began to decrease after 1992, with variations by age, race, and gender. The factors influencing the prognosis of PLB are multifaceted. And the RSF model showed promising performance, aiding clinicians in early prognosis identification and improving clinical outcomes through revised management strategies and patient care.

Indexed as

Bone NeoplasmsLymphomaAdolescentAdultAgedAged, 80 and overCohort StudiesFemaleHumansIncidenceMaleMiddle AgedPrognosisRetrospective StudiesSEER ProgramSurvival RateEpidemiologyMachine learningPrimary lymphoma of bonePrognosisSEER

Identifiers

PMID40411599
PMCPMC12283789

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.